Key Takeaways From Ag Earnings
Nutrien, Mosaic, and Compass Minerals are among the most undervalued names today in the industry.
Unfavorable weather weighed on first-quarter results for many of the agriculture companies we cover, as a delayed start to the U.S. planting season reduced sales across every crop input category. While seed sales should bounce back in the second quarter, we expect less total nitrogen and crop chemicals will be used in 2018 as the late start reduces midseason applications. However, stronger potash demand outside of North America should more than offset stagnant or slightly reduced demand in North America.
So far this year, potash and phosphate prices have been supported by reduced supply. In potash, new supply delays via lower-than-expected potash production from both SQM and K+S have led to a tighter market. We expect this dynamic to continue throughout the year, and we’ve raised our 2018 potash price forecast to $270 per metric ton. Similarly, phosphate prices have also been supported by reduced supply as production has decreased in both the U.S. (from Mosaic) and China. Accordingly, we’ve raised our 2018 price forecast to $380 per metric ton. Our long-term price forecast for potash and phosphate are unchanged at $270 and $350 per metric ton, respectively, in real terms.
From a valuation standpoint, potash producers are trading at a larger discount to fair value than the rest of our ag coverage, largely due to our long-term outlook that potash prices will remain flat, in real terms, while we forecast real price declines in nitrogen and phosphate. Nutrien and Mosaic offer the most upside based on current prices, as they trade at price/fair value ratios of 0.89 and 0.86, respectively. We view K+S as overvalued, as the firm’s higher-cost potash and salt production will limit its earnings power. We also view CF as overvalued, given our forecast for lower nitrogen prices. Although we view Best Idea Compass Minerals as undervalued, we expect profitable growth to be driven primarily by the company’s salt segment rather than its fertilizer business.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.